effect lipoprotein success rate thrombolyt therapi acut myocardi infarct lipoprotein Lp plasminogen share high degre homolog amino acid deoxyribonucl acid analysi Lp inact high level Lp profibrinolyt activ cell surfac risk arteriosclerosi thrombosi competit inhibit plasminogen present studi high level Lp influenc thrombolyt therapi patient acut myocardi infarct patient acut myocardi infarct combin low-dos thrombolyt therapi recombin tissue-typ plasminogen activ rt-pa human single-chain urokinase-typ plasminogen activ scu-pa regimen plasminemia lytic state well-maintain level fibrinogen coronari patenc minut initi treatment thrombolysi success unsuccess patient patient high Lp level equal mg/dl thrombolyt therapi patenc patient normal low level Lp patenc differ Lp level patient success unsuccess thrombolysi result high level Lp thrombolysi patient acut myocardi infarct low-dos pharmacolog concentr rt-pa scu-pa combin 